Galderma Group AG (PY3)
XDUS
Real-time Data
06:00 AM
Day's Range
182.9052 wk Range
152.60Overview - PY3 - Galderma Group AG
Key Statistics
Valuation
Enterprise Value
1.97B
P/E (Trailing)
‪70.34‬
EV / EBITDA
‪1.66‬
Profitability
Profit Margin
‪68.86%‬
Operating Margin
‪15.51%‬
Return on Assets
‪4.57%‬
Return on Equity
‪7.52%‬
Ownership
Shares Outstanding
234.56M
Price stats
50-Day Avg
‪176.80‬
200-Day Avg
‪177.18‬
Peers - PY3 - Galderma Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- PY3XDUSGalderma Group AG+7.05%52-week change70.35P/E (Trailing)‪68.86%‬Profit Margin
- 20MPXDUSThe More Life Company Corp.+77.14%52-week change-3.50P/E (Trailing)—Profit Margin
- NGQ1XDUSMedicure Inc.+74.79%52-week change-3.53P/E (Trailing)‪40.71%‬Profit Margin
- PA8XDUSPaion AG+71.80%52-week change-0.76P/E (Trailing)‪94.10%‬Profit Margin
- I76XDUSIronwood Pharmaceuticals, Inc. Class A Common Stock+59.06%52-week change21.33P/E (Trailing)—Profit Margin
- HLSXDUSAIC Mines Limited+58.86%52-week change—P/E (Trailing)—Profit Margin
- 2DTXDUSAmneal Pharmaceuticals, Inc.+50.29%52-week change76.09P/E (Trailing)‪36.87%‬Profit Margin
Profile Summary - PY3 - Galderma Group AG
About
Galderma Group AG is a Swiss healthcare company specializing exclusively in dermatology, headquartered in Zug and founded in 1981. The company focuses on skin health through three integrated business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. In injectable aesthetics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
